| Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408) |
|---|
| 02/14/2008 | WO2008005954A3 Tryphostin-analogs for the treatment of cell proliferative diseases |
| 02/14/2008 | WO2007106859A3 Phytonutrient compositions from mushrooms or filamentous fungi and methods of use |
| 02/14/2008 | US20080039662 Isomerizing an alkyl cis-4-(alkylsulfonylamino)cyclohexanecarboxylate to form the trans isomer with a base (alkali metal lower alkoxide, hydride or amide) in an aprotic solvent (toluene); forming the free acid by hydrolysis; sulfonation of alkyl 4-aminocyclohexanecarboxylate with alkylsulfinyl chloride |
| 02/14/2008 | US20080039634 Novel onium salt, electrolyte for nonaqueous cell containing the novel onium salt for nonaqueous cell and method for optimizing negative electrode using electrolyte containing onium salt |
| 02/14/2008 | US20080039442 Compounds With Kv4 Ion Channel Activity |
| 02/14/2008 | CA2666193A1 Arylaminoaryl-alkyl-substituted imidazolidine-2,4-diones, process for preparing them, medicaments comprising these compounds, and their use |
| 02/14/2008 | CA2660261A1 Heterocycles useful as inhibitors of carbonic anhydrase |
| 02/13/2008 | EP1885700A1 Imidazole salts, method for producing them, use thereof and epoxy resins containing said salts |
| 02/13/2008 | EP1885684A1 Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the beta-2 adrenergic receptor |
| 02/13/2008 | EP1885533A2 Method for impregnating lignocellulosic materials with effect agents |
| 02/13/2008 | EP1424985B1 Use of derivatives of c2-substituted indane-1-ol systems for producing medicaments for the prophylaxis or the treatment of obesity |
| 02/13/2008 | CN101124199A 5-substituted-2-phenylamino-benzamide as MEK inhibitor |
| 02/13/2008 | CN100368403C Anti anaerbic bacterial compound |
| 02/13/2008 | CN100368402C Preparation method for optical enantiomer of ornidaxole |
| 02/13/2008 | CN100367949C Melanin extinguisher |
| 02/12/2008 | US7329759 1-Substituted-[1H-indene-6,1'-cyclopropane]-4-one derivatives: solid tumors and multi-drug resistant tumors; may also be targeted to a particular tumor; can either be cytostatic or cytotoxic to the tumor cells |
| 02/12/2008 | CA2416823C Antimycotic nail varnish composition |
| 02/12/2008 | CA2383373C Synthesis of [3,5,7]-1h-imidazo[1,5-a]imidazol-2(3h)-one compounds |
| 02/12/2008 | CA2280270C Acrylonitrile compounds, process for their production and pesticides containing them |
| 02/12/2008 | CA2185207C 1-imidazolylmethyl-2-naphthols as catalysts for curing epoxy resins |
| 02/07/2008 | WO2008015240A1 N-phenyl-prenylamine derivatives for the treatment of cognitive, neurodegenerative or neuronal diseases or disorders |
| 02/07/2008 | WO2007131498A3 Salts consisting of pentafluorphenylimide anions and their use as ionic liquids |
| 02/07/2008 | WO2007098826A3 Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof |
| 02/07/2008 | WO2006005455A3 Amino, amino acid or peptide conjugates of retinoic acid |
| 02/07/2008 | US20080033209 Method For High-Purity Quaternary Ammonium Compounds |
| 02/07/2008 | US20080033182 Bisguanidine Compound Optical Resolver and Chiral Molecule Separating Agent |
| 02/07/2008 | US20080033178 Ionic Liquids |
| 02/07/2008 | US20080032986 Benzyl amines, a process for their production and their use as anti-inflammatory agents |
| 02/07/2008 | US20080029735 Surfactants and polymerizable surfactants based on room-temperature ionic liquids that form lyotropic liquid crystal phases with water and room-temperature ionic liquids |
| 02/07/2008 | DE102006035830A1 Solvent system based on molten ionic liquids containing imidazolium as cation, useful for dissolving carbohydrate and for producing regenerated carbohydrate, comprises protic solvent e.g. methanol, ethanol, 1-propanol and/or 1-butanol |
| 02/07/2008 | CA2658547A1 N-phenyl-prenylamine derivatives for the treatment of cognitive, neurodegenerative or neuronal diseases or disorders |
| 02/06/2008 | EP1884237A1 Protective agent for neurocyte comprising amidino derivative as active ingredient |
| 02/06/2008 | CN101120002A Cycloalkylfused indole, benzothiophene, benzofuran and indene derivatives |
| 02/06/2008 | CN101119965A Tetralin and indane derivatives and uses thereof |
| 02/06/2008 | CN101117334A Novel method for synthesizing L-carnosine |
| 02/06/2008 | CN101117333A Catalytic depolymerization of polymers containing electrophilic linkages using nucleophilic reagents |
| 02/06/2008 | CN100366605C Compounds to treat alzheimer's disease |
| 02/05/2008 | US7326812 Arylsulfonamidobenzylic compounds |
| 02/05/2008 | US7326792 4,5-Diphenyl-2-amino-4,5-dihydro-imidazole derivatives useful as pharmaceutical agents in treatment or prevention of diseases having an inflammatory component, including inflammatory bowel disease, rheumatoid arthritis and diseases associated with central nervous system, such as Alzheimer's disease |
| 02/05/2008 | US7326790 Diphenylisoxazole compounds and hydro isomers thereof |
| 02/05/2008 | US7326789 E.g., 2-(4-Chloro-phenylsufonylamino)-4,5-dimethoxy-N-(4-(thiomorpholine-4-sulfonyl)-phenyl)-benzamide; cardiovascular disorders; hypotensive agents; angina pectoris, cardiac insufficiency, thrombolytic agents; atherosclerosis; activating soluble guanylate cyclase to adjust a disturbed cyclic GMP balance |
| 02/05/2008 | US7326732 EP receptor (for which the endogenous ligand is prostaglandin E2, PGE2); e.g. (4-[(5-Phenyl-furan-2-carbonyl)-amino]-phenyl)-acetic acid or 5-Phenyl-furan-2-carboxylic acid [3-(1H-tetrazol-5-yl)-phenyl]-amide; dysmenorrhoea, preterm labour, glaucoma, immune disorders, inflammatory disorders |
| 02/05/2008 | US7326728 Modulators of glucocorticoid receptor, AP-1, and/or NF-κβ activity and use thereof |
| 02/05/2008 | US7326705 2-amino or carbonylamino-4-carbocyclic imidazoles and thiazoles; antiischemic agents, hypotensive agents, antiarrhythmia agents; can be coadministered with other drugs |
| 02/05/2008 | US7326696 Amino-methyl substituted tetracycline compounds |
| 02/05/2008 | CA2402686C Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same |
| 02/05/2008 | CA2284977C 3,3-disubstituted propylamines, their use and preparation |
| 02/05/2008 | CA2239795C New fongicide composition with a 2-imidazoline-5-one |
| 01/31/2008 | WO2008014291A2 Compounds and compositions as hedgehog signaling pathway modulators |
| 01/31/2008 | WO2008012974A1 Novel imidazolidinone derivative, method of producing the same and method of producing optically active amino acid |
| 01/31/2008 | WO2008012782A2 Labelled analogues of halobenzamides as radiopharmaceuticals |
| 01/31/2008 | WO2007130242A3 Hafnium complexes of heterocyclic organic ligands |
| 01/31/2008 | WO2007125034A3 Mono-nitration of aromatic compounds |
| 01/31/2008 | WO2007002559A8 Pyrazole based lxr modulators |
| 01/31/2008 | US20080027230 reacting an onium chloride with an acid resulting in formation of hydrochloric acid, formed hydrochloric acid is removed by azeotropic distillation by coordination to 1,4-dioxane which forms an azeotropic mixture with water; |
| 01/31/2008 | US20080027228 Substituted thioacetamides |
| 01/31/2008 | US20080027087 CB1 antagonists and inverse agonists |
| 01/31/2008 | US20080027060 Dipeptide nitriles |
| 01/31/2008 | US20080025915 Technetium-And Rhenium-Bis (Heteroaryl) Complexes, And Methods Of Use Thereof |
| 01/31/2008 | CA2658782A1 Compounds and compositions as hedgehog pathway modulators |
| 01/31/2008 | CA2658625A1 Substituted imidazolone derivatives, preparation and uses |
| 01/31/2008 | CA2657247A1 Compounds which modulate the cb2 receptor |
| 01/30/2008 | CN101115721A Indenyl derivatives and use thereof for the treatment of neurological disorders |
| 01/30/2008 | CN101115482A 杂环天冬氨酰蛋白酶抑制剂 Heterocyclic aspartyl protease inhibitors |
| 01/30/2008 | CN100364980C Preparation method of imidazole aromatic alcohol analog derivative with optical activity |
| 01/29/2008 | US7323570 Substituted imidazoles and thiazoles; 4-(((6-chloro-2-(3-chlorophenyl)-3-pyridinyl)methoxy)(1-methyl-1H-imidazol-5-yl)methyl)benzonitrile,antitumor agents |
| 01/29/2008 | US7323485 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds |
| 01/29/2008 | US7323484 Farnesyl transferase inhibitors |
| 01/29/2008 | US7323448 Antibacterial agents |
| 01/29/2008 | US7323433 R-(-)-1-[2-(7-chlorobenzo[b]thiopen-3-yl-methoxy)-2-(2,4-dichlorophenyl)-ethyl]-1H-imidazole |
| 01/29/2008 | US7323290 Stability, shelf-life |
| 01/29/2008 | US7323188 Composition for controlling harmful bio-organisms and method for controlling harmful bio-organisms using the same |
| 01/29/2008 | CA2226058C 8-substituted-1,3,8-triaza-spiro[4.5]decan-4-one derivatives |
| 01/24/2008 | WO2008009613A1 Non-nucleoside reverse transcriptase inhibitors |
| 01/24/2008 | WO2007103719A3 MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME |
| 01/24/2008 | US20080021231 Novel compounds |
| 01/24/2008 | US20080021079 Compounds, Compositions, and Methods |
| 01/24/2008 | US20080021055 Novel cycloalkyl derivatives as inhibitors of bone resorption and vitronectin receptor antagonists |
| 01/24/2008 | US20080020981 Non-nucleoside reverse transcriptase inhibitors |
| 01/24/2008 | CA2657723A1 Non-nucleoside reverse transcriptase inhibitors |
| 01/23/2008 | EP1879564A2 Compounds to treat amyloidosis and prevent death of beta-cells in type 2 diabetes mellitus |
| 01/23/2008 | EP1879455A1 Insecticidal substituted aminoalkyl heterocyclic and heteroaryl derivatives |
| 01/23/2008 | EP1732898B1 Tetrahydroisoquinoline- and tetrahydrobenzazepine derivatives as igf-1r inhibitors |
| 01/23/2008 | EP1206937B1 Nitroimidazole external preparations for the treatment of atopic dermatitis |
| 01/23/2008 | CN101108861A Salts comprising cyanoborate anions |
| 01/23/2008 | CN101108828A Method for synthesizing chirality secnidazole |
| 01/23/2008 | CN101108827A Method for manufacturing acetic acid type ionic liquid |
| 01/23/2008 | CN101108759A Salts comprising cyanoborate anions |
| 01/23/2008 | CN100363410C Catalytic depolymerization of polymers containing electrophilic linkages using nucleophilic reagents |
| 01/22/2008 | US7321044 Synthesis of oxygen-substituted benzocycloheptenes as valuable intermediate products for the production of tissue-selective estrogens |
| 01/22/2008 | US7321001 carboxylic acid derivatives which modulate the function and/or expression of proteins involved in atopic diseases, inflammatory conditions and cancer |
| 01/22/2008 | US7320997 Pharmaceutical compositions including carotenoid ester analogs or derivatives for the inhibition and amelioration of disease |
| 01/22/2008 | US7320983 Sulfur compounds such as phenylmethyl [2R-hydroxy-3-[(3-methylbutyl) (phenylsulfonyl)amino]-1S-(phenylmethyl)propyl]carbamate, used for prevention of viral diseases and replication |
| 01/17/2008 | WO2008007763A1 Method for producing imidazolidine-2,4-dione compound and method for obtaining solid 4,5-dihydroxy-2-imidazolidinone compound |
| 01/17/2008 | WO2008006834A2 Use of imidazole compounds as plasticisers |
| 01/17/2008 | WO2008006824A1 Novel tyrosinase inhibitors, their process of preparation and their use in human medicine and in cosmetics |
| 01/17/2008 | WO2008006432A1 Use of ampk-activating imidazole derivatives, preparation process therefor and pharmaceutical compositions comprising them |
| 01/17/2008 | WO2007100617A3 Imidazole-based compounds, compositions comprising them and methods of their use |
| 01/17/2008 | US20080015360 2,3-Dimethyl-1-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-imidazol-3-ium chloride; intermediate for preparing androstane-type glucocorticoid receptor agonists |
| 01/17/2008 | US20080015256 Tetralin and indane derivatives and uses thereof |